Archives

Colloques et séminaires

Aviesan - Symposium: RNA biology and applications

February 2^nd - 3^rd 2023, Paris

The Thematic Institute of molecular and structural biology of the French Alliance for life science (Aviesan) is programming a 2 days symposium dedicated to RNA biology and applications, that is a very active field with emerging topics.

Registration.

MDPI - Conference: 3rd IECC

March 16^th - 30^th 2023, virtual

The open access publisher MDPI and its review Cancer sponsor the 3^rd International Electronic Conference on Cancers: New Targets for Cancer Therapies (IECC 2023), which aims to promote and advance the coordinated progress in oncology research to foster the development of innovative therapeutic strategies. There will be 5 sessions:

Genome-wide Approaches for Target Identification;
Targeting Metastasis;
Novel Immunotherapy Targets;
Novel Approaches for ‘Undruggable’ Targets,
Overcoming Therapeutic Resistance.

Deadline for abstract submission: January 5^th 2023.

Matwin - Convention: Meet2win

May 11^th - 12^th 2023, Bordeaux

Matwin will organise its 8^th Meet2win, a two-day partnering convention combining conferences, collaborative sessions, projects’ pitches, one-to-one prescheduled business meetings as well as an exhibition area.

Divers

ICPerMed - Open consultation

The EP PerMed is one of the European research and innovation partnerships under Horizon Europe which will be dedicated to maximising the benefits of personalised medicine (PM) approaches.The EP PerMed Drafting Group, representing the European Members States group, is launching an open consultation to validate and receive input for the Strategic Research and Innovation Agenda in support for the EP PerMed.

Closure of the consultation: December 21^st 2022.

Access to the consultation.

Et toujours d'actualité

Appels à projets ou candidatures

Inserm - AMI : objectif Projets européens collaboratifs

L'Inserm lance des appels à manifestation d’intérêt concernant deux thématiques visées par les futurs appels à projets collaboratifs d'Horizon Europe. L'objectif est de faire émerger des collaborations entre équipes Inserm ayant des expertises complémentaires, afin de construire un ou plusieurs projet(s) européen(s) à coordination Inserm.

Date limite d'inscription : 12 Décembre 2022.

Consulter l'AMI "Rôle de la pollution environnementale dans les maladies non transmissibles".

Consulter l'AMI "Prévention personnalisée des maladies non transmissibles".

Sanofi - AAC : iDEA-iTECH Awards 2023

Les Sanofi iDEA-iTECH Awards permettent de soutenir des projets innovants et de rupture sur de multiples thématiques, notamment, en 2023, sur la médecine de précision en oncologie.

Date limite de candidature : 16 décembre 2022.

Anses - AAP : PNR-EST généraliste

L’appel à projets généraliste du Programme national de recherche Environnement-Santé-Travail de l'Anses (Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail) vise les questions prioritaires identifiées dans les politiques publiques actuelles (plans santé environnement, santé au travail, cancer). Chaque année, l'ITMO Cancer d'Aviesan finance plusieurs projets relatifs au cancer retenus dans le cadre de ce programme. Parmi les sujets d’intérêt :

effets du changement climatique sur les facteurs de risques sanitaires ;
effets des agents chimiques dont les perturbateurs endocriniens,
facteurs favorisant les cancers ;
exposition des travailleurs aux risques émergents et impacts des nouvelles technologies et organisations du travail ;
formes de mobilisations et de participations citoyennes utiles pour l’évaluation et la prise en compte des risques.

Un budget supplémentaire est prévu pour financer des projets spécifiques sur l’effet de la qualité de l’air sur la santé. Par ailleurs, des projets portant sur l’étude de l’exposome ou incluant dans leur approche le concept "One health" sont également attendus.

Date limite de soumission des lettres d'intention : 5 Janvier 2023 à midi.

Date limite de dépôt des dossiers complets (LI sélectionnées) : 6 Avril 2023 à midi.

Consulter l'AAP.

Fondation ARC - AAP : programmes labellisés 2023

Les Programmes labellisés Fondation ARC visent à soutenir des travaux d’envergure, portés par une équipe ou un consortium de recherche, s’appuyant sur des bases solides qui aboutiront à une meilleure compréhension et une meilleure prise en charge des cancers.

Date limite de candidature : 9 Janvier 2023.

Consulter l'AAP.

Anses - AAP : PNR-EST "Radiofréquences et santé"

L’appel à projets "Radiofréquences et santé" du Programme national de recherche Environnement-Santé-Travail de l'Anses (Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail) concerne 4 thèmes :

mécanismes d'action au niveau moléculaire et cellulaire ;
effets physiologiques et sanitaires des radiofréquences ;
hypersensibilité électromagnétique ;
caractérisation des expositions.

Dans le contexte actuel du déploiement de la 5G, les recherches portant sur les bandes de fréquences disponibles en France seront prioritaires.

Date limite de soumission des lettres d'intention : 17 Janvier 2023 à midi.

Date limite de dépôt des dossiers complets (LI sélectionnées) : 16 Mai 2023 à midi.

Consulter l'AAP.

FFRD - AAP : GenOmics of Rare Diseases 2022

The Foundation For Rare Diseases (FFRD, Fondation maladies rares) launches its 2022 call for research projects, dedicated to applications of next generation sequencing to unravel genetic and molecular bases of rare diseases. Projects concerning benign tumors as well as systemic rare diseases involving tumor development are in the scope of this call.

Deadline for application: January 19^th 2023, 5:00 pm.

See the Call.

CE Horizon Europe - AAC : ERC Proof of Concept Grants 2023

The ERC Proof of Concept Grants aim at facilitating exploration of the commercial and social innovation potential of ERC funded research, by funding further work (i.e. activities which were not scheduled to be funded by the original ERC frontier research grant) to verify the innovation potential of ideas arising from ERC funded projects. Proof of Concept Grants are therefore on offer only to Principal Investigators whose proposals draw substantially on their ERC funded research.

Deadlines for application (multiple cut-off):

January 24^th 2023, 17:00 (Brussels time).

April 20^th 2023, 17:00 (Brussels time).

September 21^st 2023, 17:00 (Brussels time).

Fondations ARC & autres - AAP : Programme ATTRACT

La Fondation ARC s’associe à quatre organismes caritatifs européens de lutte contre le cancer pour promouvoir la recherche clinique sur les cancers rares, à travers le programme ATTRACT (Accelerate Together Rare Cancer Treatment) : FC AECC (Espagne), Anticancer Fund (Belgique), Kom op tegen Kanker (Belgique) et KWF Dutch Cancer Society (Pays-Bas), coordonnateur de cette action.

Date limite de candidature (pré-projets) : 31 Janvier 2023 à midi.

Date limite de candidature (projets complets) : 27 Juin 2023 à midi.

A télécharger : Guidelines for applicants, Instructions-GMS et Registration form GMS.

S'inscrire aux réunions d'informations sur le programme (1^er Décembre 2022 et 9 Janvier 2023).

CE Horizon Europe - AAC : ERC Consolidator Grants 2023

The ERC Consolidator Grants are designed to support excellent Principal Investigators at the career stage at which they may still be consolidating their own independent research team or programme. Principal Investigators must demonstrate the ground-breaking nature, ambition and feasibility of their scientific proposal.

Deadline for application: February 2^nd 2023, 17:00 (Brussels time).

CE Horizon Europe - AAC : MSCA Cofund 2022

MSCA (Marie-Sklodowska-Curie Actions) COFUND co-finances new or existing doctoral programmes and postdoctoral fellowship schemes with the aim of spreading the best practices of the MSCA including international, inter-sectoral and interdisciplinary research training, as well as international and cross-sectoral mobility of researchers at all stages of their career.

Deadline for application: February 9^th 2023, 17:00 (Brussels time).

Matwin - AAP : Programme accélérateur

En s’appuyant sur l’écosystème en place sur le territoire (cancéropôles, SIRIC, structures de valorisation, pôles, etc.) et le réseau préclinique et clinique d’Unicancer, MATWIN sélectionne et accompagne des projets de recherche d’excellence en oncologie à fort potentiel de développement.

Date limite de candidature (parcours accéléré) : 28 Février 2023.

Fondation ARC - AAP : SIGN'IT 2023

L’objectif de l’appel à projets Signatures en immunothérapie (SIGN’IT) de la Fondation ARC est de mobiliser les compétences françaises autour de projets originaux dans le domaine de l’immunothérapie. Il s'agira de traiter des questions complexes relatives à l’identification de signatures permettant de guider la décision thérapeutique et, au mieux, de sélectionner les patients susceptibles de bénéficier de ces traitements.

Date limite de candidature : 7 Mars 2023 à midi.

Consulter l'AAP (FR ou EN).

CE Horizon Europe - AAC : MSCA Staff Exchanges 2022

MSCA (Marie-Sklodowska-Curie Actions) Staff Exchanges involve organisations from the academic and non-academic sectors (including SMEs) from across the globe. Support is provided for international, inter-sectoral and interdisciplinary mobility of R&I staff leading to knowledge transfer between participating organisations.

Deadline for application: March 8^th 2023, 17:00 (Brussels time).

Fondation ARC - AAC : Recruiting international leaders in oncology 2023

By offering a significant support, the Fondation ARC call for proposal "Recruiting international leaders in oncology" wishes to allow the implantation in France of new scientific leader that will establish his/her team and carry out ambitious research in oncology.

Deadline for application: March 14^th 2023.

See the Call.

ANR - AAC : SRSEI 2022

Dans le cadre de la composante « Construction de l’espace européen de la recherche et attractivité internationale » du Plan d’action 2022 de l'Agence nationale de la recherche, l’instrument SRSEI (Soutien aux réseaux scientifiques européens ou internationaux) est proposé avec un format de dépôt en continu. SRSEI a été créé pour donner les moyens aux scientifiques travaillant dans des laboratoires français ayant déposé en tant que coordinatrice/coordinateur un projet de recherche à des appels collaboratifs européens (Horizon Europe) ou internationaux de renforcer la qualité de leur candidature (proposition complète ou audition) pour la dernière étape de l’appel visé.

Consulter l'AAC.

Télécharger le document scientifique.

Candidater (dépôt en continu).

Colloques et séminaires

EPHE/UB - Colloque : 10es JIIC

13-15 Décembre 2022, Dijon

Les Journées d'immunologie et immunothérapie des cancers (JIIC), organisées par le laboratoire d'immunologie et immunothérapie des cancers (École pratique des hautes études/université de Bourgogne), sont l'occasion de présenter une mise à jour des connaissances générales et une synthèse des derniers résultats dans ce domaine de recherche.

Cancéropôle IdF - 16e colloque annuel

17 Janvier 2023, en ligne

Le 16^e colloque annuel du Cancéropôle Île-de-France aura pour thème "L’hétérogénéité tumorale et la plasticité à travers l’espace et le temps".

Inscription gratuite mais obligatoire.

EACR - Conference: Trailblazing Cancer Prevention

January 31^st 2023, virtual

This virtual showcase organised by EACR will present leading paradigms in cancer prevention research, featuring a panel of trailblazers who will share progress on early detection and cancer vaccines, and insights on the links between epidemiology, genetic risk, and personalised cancer management.

Deadline for registration: January 16^th 2023.

EACR/Boehringer Ingelheim - Conference: The MAP Kinase Pathway

February 21^st - 22^nd 2023, virtual

This EACR/Boehringer Ingelheim joint conference entitled "Drugging and Regulating the MAP Kinase Pathway" will focus on basic and clinical aspects of the regulation of signaling through the MAPK pathway and its impact in cancer, with 4 topics to be covered:

Regulation of MAPK signaling;
Drug resistance mechanisms;
Rational combination therapies;
Cross-resistance to immune modulators.

Deadline for registration: January 23^rd2023.

EACR/AACR/SIC - Conference: Immune Responses & DNA Repair

March 15^th - 17^th 2023, Florence (Italy)

The basic and translational research conference "Immune Responses & DNA Repair - Cancer Fields Converging" is jointly organised by EACR (European association for cancer research), AACR (American association for cancer research) and SIC (Italian cancer society).

Deadline for early bird registration: January 13^th 2023.

EACR/OECI - Conference: Molecular Pathology Approach to Cancer

March 28^th - 30^th 2023, Bergamo (Italy)

This meeting organised by EACR and the Organisation of European cancer institutes (OECI) will provide participants with a broad view of the scope, methodologies, future directions and challenges in addition to practical approaches for molecular pathology in research and in clinical settings. The potential uses of deep learning in pathology will be discussed.Four topics will be covered:

Current views on molecular pathology;
Molecular pathology of colorectal cancer;
Cancer models for biomarker discovery, from animal models to patient derived organoids;
New technologies in diagnostic onco-pathology.

Deadline for abstract submission: January 30^th 2023.

Deadline for registration: February 27^th 2023.

Cancéropôle IdF - Colloque : Cancers rares, cancers fréquents

30 Mars 2023, Paris

Le Cancéropôle Île-de-France et son groupe de travail “Cancers et tumeurs rares” organisent la journée "Cancers rares, cancers fréquents : qu'ont-ils en commun?", qui permettra d’identifier les points communs dans la maladie et dans les traitements de manière à faire bénéficier les cancers rares des avancées de recherche sur les cancers fréquents.

Inscription gratuite mais obligatoire.

EACR - Conférence : Stem Cell Biology

April 25^th - 26^th 2023, virtual

This EACR conference entitled "Stem Cell Biology, Cancer Plasticity and Therapeutic Potential" will present leading experts sharing the more recent advancement in tissue stem cells biology and the link to cancer heterogenicity and plasticity, around 3 main topics:

Fundamental of tissue stem cells biology;
Stem cell niches and aging;
Drivers of cellular plasticity in cancer.

Deadline for abstract submission: February 13^th 2023.

Deadline for registration: March 27^th 2023.

Fondation ARC - Symposium : Signatures in cancer immunotherapy

SAVE THE DATE

28 Avril 2023, Paris

Lors de ce symposium organisé par la Fondation ARC, les lauréats des différentes éditions de l’appel à projets SIGN’IT exposeront l’avancée de leurs travaux. Cette journée est ouverte à tous les membres de la communauté scientifique et médicale, française et internationale, s’intéressant à la recherche sur les immunothérapies.

Modalités à venir.

Programme & more information.

EMBO - Workshop: Systems biology/Epigenetics

May 25^th - 29^th 2023, Alexandroupoli (Greece)

EMBO (European molecular biology organisation) will organise a workshop entitled "Systems Biology: Linking chromatin and epigenetics to disease and development".

Deadline for abstract submission: March 14^th 2023.

Deadline for registration: March 14^th 2023.

EACR - Conference: Defence is the Best Attack

May 9^th – 11^th 2023, Barcelona (Spain)

This EACR conference entitled "Defence is the Best Attack: Immuno-Oncology Breakthroughs" is dedicated to the most recent advances in the field of immunotherapy, from the basic science to clinical studies. Seven topics will be covered:

Immune checkpoints;
Innate immune response;
Microbioma;
Immune cell therapies;
Vaccines;
Biomarkers of response to immunotherapy;
Mechanisms of resistance to immunotherapy.

Deadline for abstract submission: February 13^th 2023.

Deadline for registration: March 13^th 2023.

EACR - 2023 Congress: Innovative Cancer Science

June 12^th - 15^th 2023, Torino (Italy)

The 29^th Congress of the European Association for Cancer Research (EACR) will focus on Innovative Cancer Science.

Deadline for abstract submission: March 6^th 2023.

Deadline for early registration: April 24^th 2023.

EACR - Conférence : Early Career Researchers

June 27^th - 28^th 2023, virtual

This conference organised by EACR will be a highly interactive, workshop-style online conference for early-career researchers wishing to develop their career in cancer research.

Deadline for registration: May 29^th 2023.

Sign-up to be notified when registration opens.

EMBO - Workshop: Imaging the immune system

June 28^th - 30^th 2023, Lugano (Switzerland)

This EMBO (European molecular biology organisation) workshop will dedicate a plenary session to "Imaging cancer-immune system interactions".

Deadline for abstract submission: April 15^th 2023.

Deadline for registration: April 15^th 2023.

Fusion Conferences - Conference: Animal Models of Cancer

July 18^th - 23^rd 2023, Lisbon (Portugal)

The conference "Animal Models of Cancer: From Cancer Genetics to Precision Oncology" will focus on three major areas:

How to generate precise and complex genetic alterations in mice and other animals to better “humanize” models ?
How to investigate fundamental mechanisms of cancer initiation and progression, including the cell of origin of tumors, their evolution, their metabolism, and their interactions with the immune system?
How genetically engineered animal models can help evaluate the efficacy of novel therapeutic approaches and to decipher mechanisms of therapeutic resistance?

Deadline for talk submission: February 6^th 2023.

Deadline for poster submission: May 19^th 2023.

Deadline for registration: May 19^th 2023.

HSLB - Meeting: 6th Advances in Circulating Tumor Cells

September 20^th - 23^rd 2023, Skiathos Island (Greece)

The Hellenic Society of Liquid Biopsy (HSLB) organises its 6^th Advances in Circulating Tumor Cells (ACTC) entitled "Liquid Biopsy and Precision Oncology: Where do we stand now?". Late breaking news on CTCs, ctDNA, circulating miRNAs and extracellular vesicles technologies and their clinical applications will be presented at this international meeting.

Deadline for abstract submission: May 15^th 2023.

Deadline for early registration: July 31^st 2023.

Programme (upcoming).

EACR - Conference: Goodbye Flat Biology

October 10^th - 12^th 2023, Berlin (Germany)

This EACR conference will focus on the next generation of cancer models and emerging topics in the areas of cell architecture, mechanobiology, the immune microenvironment, intravital imaging and high-content analysis for cancer therapeutics. Four topics will be covered:

Molecular regulation of cancer cell adhesion, invasion, migration, and survival;
Force generation and mechanotransduction in tumors;
Interactions of cancer cells with the immune and fibroblastic microenvironment;
3D in vitro systems for target identification and compound screening.

Deadline for abstract submission: July 3^rd 2023.

Deadline for registration: September 1^st 2023.

EMBO - Symposium : Organoids

October 18^th - 21^st 2023, Heidelberg (Germany) & Virtual

The aim of this meeting organised by the European Molecular Biology Organisation (EMBO) is to bring together researchers from different fields to enhance our understanding of:

How organoids can be formed and maintained;
How they can be used to study disease;
How eventually use them to regenerate and replace human organ tissue.

Deadline for abstract submission: July 26^th 2023.

Deadline for registration: September 6^th 2023 (on-site) or October 11^th 2023 (virtual).

Formation

IARC - AAC : IARC Summer School 2023

The IARC (International Agency for Research on Cancer) Summer School is designed for researchers and health professionals involved in cancer prevention and cancer control. Tailored to foster international collaboration, the IARC Summer School offers a unique multicultural and multidisciplinary learning environment. Two modules were designed for 2023:

Introduction to cancer epidemiology (overview);
Implementing cancer prevention and early detection (overview).

Date limite de candidature: January 15^th 2023.

Offres d'emploi

BRIC - AAC : 3 postes

The Bordeaux Institute of Oncology is recruiting for its teams:

A 3-year postdoctorant in cancer biology, to contribute to the validation of Fascin-1 as a therapeutic target in hepatoblastomas.

Deadline for application: December 9^th 2022.

See the Call.

A junior group leader, to develop innovative research programs on the biology of aging and cancer.

Deadline for application: December 15^th 2022.

See the Call.

A 2-year postdoctorant in bioinformatics, to decipher the tumor heterogeneity in Sézary Syndrome.

Deadline for application: May 1^st 2023.

See the Call.

CRCL - 3 Post-doc positions

The Lavial Lab "Reprogramming stem cells and oncogenesis" in CRCL is seeking:

2 post-doc scientists with strong background in cancer and/or reprogramming biology, to explore the control of cellular identity and plasticity during oncogenic transformation and reprogramming:

See the Call.

1 bioinformatician (engineer or post-doc), to explore the cellular trajectories of oncogenic transformation and reprogramming:

See the Call.

Contract start date: between January and April 2023.

Institut Curie - CDD : Chef d'équipe

L'unité Cancer, Hétérogénéité, Instabilité et Plasticité de l'Institut Curie recrute un nouveau chef de groupe pour renforcer ses programmes sur les mécanismes fondamentaux du cancer (Hallmarks of cancer), avec un accent particulier sur les cancers de l'enfant.

Date limite de candidature : 1^er Janvier 2023.

Voir la fiche de poste.

Institut Cochin - Team leader

Institut Cochin is opening a position for a scientist wishing to establish his/her independent team in one or another scientific axes covered by the Institut: Cancer, Immunology, Metabolism-Endocrinology, Microbiology, and Genetic and Cellular Plasticity.

Deadline for application: January 27^th 2023.

See the Call.

Inserm (DESP) - CDD : Chargé(e) d'évaluation des AAP Cancer

L'Inserm assure la gestion scientifique et administrative des appels à projets programmés par l'ITMO Cancer Aviesan dans le cadre de la Stratégie décennale de lutte contre le cancer. Au sein du département de l’évaluation et du suivi des programmes (DESP) de l'Inserm, la personne recrutée aura pour mission de gérer l'évaluation scientifique des appels à projets, en collaboration avec la coordinatrice.

Date de prise de fonction souhaitée : dès que possible.

Voir la fiche de poste.

CRBM - Post-doc Position

In the frame of the INCa funded project “Targeting oncogenic pseudokinases in leukemia", a 30-36 months CDD for a post-doc position is available at the Centre de recherche en biologie cellulaire de Montpellier, in the team Cancer Cell Signalling.

Starting date: Late 2022 or early 2023.

See the Call.

Inserm U 1109 - Research engineer position on Tumor Microenvironment

In the frame of the INCa PLBIO funded project “Matrix-CAR-Targeting”: anti-tumor immunity by targeting the extracellular matrix with CAR T cells, a 36 months position (research engineer) starting in spring 2023 is available in the Tumor Microenvironment group of the Inserm Unit 1109 in Strasbourg.

See the Call.

Institut Curie - Post-doc Position

A 3-year post-doctoral position is available for a project in collaboration between the Group “Notch signaling in stem cells and tumors” directed by Silvia Fre and the Group “Polarity, Division and Morphogenesis” directed by Yohanns Bellaiche in the Department of Genetics and Developmental Biology (UMR3215/U934) at Institut Curie in Paris, France.

See the Call.

Institut Curie/Institut de la vision - Post-doc Position

A 4-year post-doctoral position is available for a project in collaboration between the Group “Notch signaling in stem cells and tumors” directed by Silvia Fre in the Department of Genetics and Developmental Biology (UMR3215/U934) at Institut Curie and the Group “Development and function of the vertebrate visual system” directed by Filippo Del Bene at the Institut de la Vision in Paris, France.

See the Call.

Gustave-Roussy - Post-doc Position

A post-doctoral position is available at the Gustave Roussy Cancer Campus Research Center in Paris area (Villejuif, France) in the team "Biology of pediatric leukemia" led by Thomas Mercher.

See the Call.